XOMA royalty-2c.png
XOMA Corporation Announces Closing of Tender Offer
03 avr. 2024 09h00 HE | XOMA Corporation
XOMA completes acquisition of Kinnate.
XOMA royalty-2c.png
XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right
16 févr. 2024 08h00 HE | XOMA Corporation
XOMA enters agreement to acquire Kinnate for cash and CVR; Expects to add $9.5M cash to balance sheet upon completion of acquisition
XOMA royalty-2c.png
FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx
11 janv. 2024 16h05 HE | XOMA Corporation
EMERYVILLE, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today that based upon the U.S. Food and Drug Administration’s (FDA)...
XOMA royalty-2c.png
XOMA Declares Quarterly Preferred Stock Dividends
20 déc. 2023 07h30 HE | XOMA Corporation
January quarterly dividend payment to XOMAP and XOMAO stockholders of record on 1/3/2024
XOMA royalty-2c.png
XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio
30 mars 2023 07h30 HE | XOMA Corporation
EMERYVILLE, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), announced today it has acquired the commercial payment and a portion of the milestone rights to IXINITY®...
XOMA-Logo-Final.png
XOMA Declares Quarterly Preferred Stock Dividends
22 déc. 2022 07h30 HE | XOMA Corporation
EMERYVILLE, Calif., Dec. 22, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to...
XOMA-Logo-Final.png
XOMA Declares Quarterly Preferred Stock Dividends
21 sept. 2022 07h30 HE | XOMA Corporation
EMERYVILLE, Calif., Sept. 21, 2022 (GLOBE NEWSWIRE) --  XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends...